MedPath

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin

Not Applicable
Recruiting
Conditions
Labor Induction
Cesarean Delivery
Interventions
Device: Foley balloon
Registration Number
NCT07006896
Lead Sponsor
University of Pennsylvania
Brief Summary

A randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxytocin use at the start of the induction. With this trial, the investigators aim to test our central hypothesis that concurrent Foley and Oxytocin will decrease time to delivery without increasing risks, compared to Foley alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Eligible for induction of labor
  • Live singleton gestation ≥37 weeks
  • History of 1 cesarean delivery
  • ≥18 years of age
  • Cephalic presentation
  • Intact membranes
  • English or Spanish speaking (Able to read/understand consent and instructions)
  • Cervical dilation <3cm and Bishop score <8
Exclusion Criteria
  • >1 prior Cesarean delivery
  • Known chorioamnionitis
  • Major fetal anomaly

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Concurrent Foley balloon and OxytocinFoley balloonCervical ripening will begin with a Foley balloon and concurrent oxytocin, started within 2 hour of balloon placement
Concurrent Foley balloon and OxytocinOxytocinCervical ripening will begin with a Foley balloon and concurrent oxytocin, started within 2 hour of balloon placement
Foley balloon aloneFoley balloonCervical ripening will begin with a Foley balloon alone. Oxytocin will not be started until the balloon is removed or expelled, though can be considered if the balloon remains in place for \>8 hours
Primary Outcome Measures
NameTimeMethod
Time to deliveryAt delivery

The primary endpoint will be time from start of induction until delivery (hours)

Secondary Outcome Measures
NameTimeMethod
Estimated postpartum blood lossAt delivery

Estimated postpartum blood loss in mL

Postpartum hemorrhageWithin 6 weeks of delivery

Estimated blood loss≥ 1L

Number of Participants with ChorioamnionitisAt delivery

Documented chorioamnionitis

Mode of deliveryAt delivery

Successful vaginal birth after cesarean (VBAC) or repeat cesarean delivery (rCD)

Number of Participants with Uterine RuptureAt delivery

Uterine rupture noted at the time of cesarean delivery

Maternal morbidityWithin 6 weeks of delivery

Defined as a composite endpoint consisting of at least one occurrence of the following outcomes: postpartum hemorrhage, blood transfusion, endometritis, wound/laceration breakdown or infection, venous thromboembolism and hospital readmission with 6 weeks

Neonatal morbidityWithin 6 weeks of delivery

Defined as neonatal resuscitation requiring supplemental oxygen outside of the delivery room for at least 12 hours of culture proven/presumed neonatal sepsis

Maternal length of stayFrom date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery

Measured by hours from admission to postpartum discharge

Neonatal length of stayFrom date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery

Length of stay from birth to discharge, measured in hours

NICU stay greater than 48 hoursFrom date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery

Admission to the NICU for more than 48 hours

Maternal patient satisfaction as measured by the Hollins Martin Birth Satisfaction scale-Revised (BSS-R)From time of delivery to discharge from hospital, up to 6 weeks from delivery

Patient satisfaction as measured by the BSS-R with a possible score of 0-40 with 0 equaling the least birth satisfaction

Trial Locations

Locations (1)

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Hospital of the University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
Hannah Foster, MD
Contact
267-879-4930
hannah.foster@pennmedicine.upenn.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.